🇺🇸 Candel Therapeutics, Inc.
Forum topic · CADL · Company page: financials, ownership and filings
Market value
$679 M
Automatic updates
2
Mutual funds 1 · Results 1
Member comments
0
approved by an editor
Reactions
0
Join the discussion on Candel Therapeutics, Inc.
Loading…
Results announced on 12 November 2026
Candel Therapeutics, Inc. announced results on 12 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $22 million.
Mutual funds: 96 funds hold $190 million
96 mutual funds in 1 country hold shares of Candel Therapeutics, Inc. worth $190 million, about 26.2% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 71 funds added shares and 13 sold; on balance they bought $41 million. Share splits are not counted as trading.